Balance Sheet Sino-Agri Leading Biosciences Co.,Ltd

Equities

603970

CNE100002TN4

Agricultural Chemicals

End-of-day quote Shanghai S.E. Other stock markets 2026-01-12			5-day change	1st Jan Change
13.19 ^CNY	+0.76%		+2.01%	+2.57%

11-18	Sino-Agri Leading Biosciences Scraps Plans to Acquire Taizhou Agricultural Materials	MT
11-18	Sino-Agri Leading Biosciences Nixes Stake Acquisition of Taizhou Agricultural Materials	MT

462d34ff1d5c742c403.UuXp49YNwZU-wWJAhzM1e-NqqL-5704kC1Ip_TVFrmQ.Ioua1LJJ-PEKmVUjzUthHaIcneWUpXp2TQhxz2BxxC9r1KG6kkOXwWaXUg

Published financial data: SINO-AGRI LEADING BIOSCIENCES CO.,LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	6.64B	8.82B	11.7B	10.46B	10.6B
Total Revenues	6.64B	8.82B	11.7B	10.46B	10.6B
Cost of Goods Sold, Total	6.13B	8.29B	10.97B	9.76B	9.88B
Gross Profit	516M	530M	727M	702M	718M
Selling General & Admin Expenses, Total	234M	249M	295M	320M	322M
Provision for Bad Debts	5.45M	-1.61M	2.54M	27.88M	17.87M
R&D Expenses	34.04M	37.53M	45.79M	65.36M	66.74M
Other Operating Expenses	3.45M	10.58M	9.38M	6.88M	38.38K
Other Operating Expenses, Total	277M	295M	352M	420M	407M
Operating Income	239M	235M	374M	281M	312M
Interest Expense, Total	-44.95M	-33.84M	-26.76M	-15.63M	-22.44M
Interest And Investment Income	22.4M	66.55M	28.65M	39.66M	18.45M
Net Interest Expenses	-22.54M	32.71M	1.9M	24.02M	-3.99M
Currency Exchange Gains (Loss)	-22.57M	13.87M	-15.19M	-16.22M	-34.32K
Other Non Operating Income (Expenses)	-3.82M	-8.24M	-29.78M	1.12M	-11.3M
EBT, Excl. Unusual Items	190M	273M	331M	290M	296M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	17.57M	-13.55M	-18.55M	11.83M	1.26M
Gain (Loss) On Sale Of Assets	387K	296K	-765K	708K	-578K
Asset Writedown	-312K	-27.19M	293K	-244K	-19.71K
Insurance Settlements	-	-	-	-	-
Other Unusual Items	34.91K	7.35M	13.42M	12.62M	5.01M
EBT, Incl. Unusual Items	207M	240M	326M	315M	302M
Income Tax Expense	52.41M	54.6M	77.78M	67.55M	73.23M
Earnings From Continuing Operations	155M	186M	248M	248M	229M
Net Income to Company	155M	186M	248M	248M	229M
Minority Interest	-22.61M	-15.33M	-37.58M	-22.74M	-25.5M
Net Income - (IS)	132M	170M	210M	225M	203M
Net Income to Common Incl Extra Items	132M	170M	210M	225M	203M
Net Income to Common Excl. Extra Items	132M	170M	210M	225M	203M
Per Share Items
Net EPS - Basic	0.49	0.63	0.78	0.84	0.76
Basic EPS - Continuing Operations	0.49	0.63	0.78	0.84	0.76
Basic Weighted Average Shares Outstanding	269M	269M	269M	269M	269M
Net EPS - Diluted	0.49	0.63	0.78	0.84	0.76
Diluted EPS - Continuing Operations	0.49	0.63	0.78	0.84	0.76
Diluted Weighted Average Shares Outstanding	269M	269M	269M	269M	269M
Normalized Basic EPS	0.36	0.58	0.63	0.59	0.59
Normalized Diluted EPS	0.36	0.58	0.63	0.59	0.59
Dividend Per Share	0.21	0.25	0.39	0.45	0.45
Payout Ratio	70.16	55.61	44.83	54.9	71.31
Supplemental Items
EBITDA	248M	245M	387M	292M	322M
EBITA	244M	240M	378M	282M	312M
EBIT	239M	235M	374M	281M	312M
EBITDAR	262M	250M	389M	311M	342M
Total Revenues (As Reported)	6.64B	8.82B	11.7B	10.46B	10.6B
Effective Tax Rate - (Ratio)	25.26	22.73	23.88	21.44	24.24
Total Current Taxes	50.6M	61.51M	91.31M	75.24M	68.39M
Total Deferred Taxes	1.81M	-6.91M	-13.53M	-7.69M	4.84M
Normalized Net Income	96M	156M	169M	159M	160M
Non-Cash Pension Expense	1.54M	279K	55.67K	67.66K	-
Supplemental Operating Expense Items
Advertising Expense	25.71M	25.83M	40.44M	48.03M	55.36M
Selling and Marketing Expenses	171M	181M	224M	244M	242M
General and Administrative Expenses	51.36M	65.37M	70.28M	74.75M	79.35M
Research And Development Expense From Footnotes	34.04M	37.98M	46.24M	65.36M	66.74M
Net Rental Expense, Total	14.11M	4.4M	1.57M	19.3M	19.97M
Imputed Operating Lease Interest Expense	5.41M	1.14M	360K	2.91M	5.16M
Imputed Operating Lease Depreciation	8.71M	3.25M	1.21M	16.39M	14.81M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1B	967M	1.93B	864M	405M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	504M	507M	1B	792M	1B
Total Cash And Short Term Investments	1.51B	1.47B	2.93B	1.66B	1.41B
Accounts Receivable, Total	624M	199M	321M	1.71B	1.69B
Other Receivables	49.61M	37.94M	116M	59.03M	49.42M
Total Receivables	673M	237M	437M	1.77B	1.74B
Inventory	1.24B	1.72B	1.56B	1.54B	1.57B
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	415M	1.08B	1.05B	779M	634M
Total Current Assets	3.83B	4.5B	5.98B	5.74B	5.35B
Gross Property Plant And Equipment	106M	141M	143M	150M	149M
Accumulated Depreciation	-64.08M	-67.21M	-82.92M	-78.57M	-90.08M
Net Property Plant And Equipment	42.06M	73.77M	60.39M	71.84M	58.53M
Long-term Investments	5.84M	86.17M	113M	99.13M	95.09M
Goodwill	-	-	-	-	-
Other Intangibles, Total	119M	50.53M	5.14M	4.29M	3.65M
Deferred Tax Assets Long-Term	21.78M	25.3M	42.44M	50.38M	43.95M
Deferred Charges Long-Term	2.34M	1.69M	1.48M	2.53M	5.67M
Other Long-Term Assets, Total	-	-	42M	42M	42M
Total Assets	4.02B	4.74B	6.24B	6.01B	5.6B
Liabilities
Accounts Payable, Total	964M	1.3B	2.65B	2.76B	2.12B
Accrued Expenses, Total	59.99M	40.48M	75.32M	81.12M	83.75M
Short-term Borrowings	1.12B	942M	801M	629M	628M
Current Portion of Long-Term Debt	7.5M	-	85.56K	100M	-
Current Portion of Leases	-	9.71M	3.5M	10.05M	8.73M
Current Income Taxes Payable	20.67M	24.68M	55.09M	30.86M	25.19M
Unearned Revenue Current, Total	544M	893M	932M	624M	898M
Other Current Liabilities	147M	221M	117M	153M	140M
Total Current Liabilities	2.86B	3.43B	4.63B	4.39B	3.9B
Long-Term Debt	-	-	100M	-	-
Long-Term Leases	-	5.46M	5.61M	9.29M	4.32M
Unearned Revenue Non Current	9.87M	8.39M	-	326K	146K
Deferred Tax Liability Non Current	4.81M	12.11M	15.72M	12.58M	9.74M
Other Non Current Liabilities	5.82M	5.59M	6.01M	4.28M	4.28M
Total Liabilities	2.88B	3.46B	4.76B	4.41B	3.92B
Common Stock, Total	192M	192M	192M	269M	269M
Additional Paid In Capital	298M	298M	302M	238M	238M
Retained Earnings	535M	648M	791M	910M	993M
Comprehensive Income and Other	-161K	33M	32.93M	22.2M	20.69M
Total Common Equity	1.03B	1.17B	1.32B	1.44B	1.52B
Minority Interest	118M	110M	166M	155M	162M
Total Equity	1.14B	1.28B	1.48B	1.59B	1.68B
Total Liabilities And Equity	4.02B	4.74B	6.24B	6.01B	5.6B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	269M	269M	269M	269M	269M
ECS Total Common Shares Outstanding	269M	269M	269M	269M	269M
Book Value / Share	3.81	4.36	4.9	5.36	5.66
Tangible Book Value	906M	1.12B	1.31B	1.44B	1.52B
Tangible Book Value Per Share	3.37	4.17	4.89	5.34	5.64
Total Debt	1.12B	957M	910M	748M	642M
Net Debt	-384M	-517M	-2.02B	-908M	-764M
Debt Equivalent Oper. Leases	113M	35.18M	12.57M	154M	160M
Minority Interest, Total (Incl. Fin. Div)	118M	110M	166M	155M	162M
Equity Method Investments, Total	2.06M	2.17M	29.28M	29.6M	30.57M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	39.49M	44.43M	37.64M	45.89M	48.96M
Inventories - Work In Process, Total	4.78M	2.35M	1.66M	4.58M	3.94M
Inventories - Finished Goods, Total	1.22B	1.7B	1.57B	1.57B	1.59B
Inventories - Others	4.54M	4.51M	3.28M	2.41M	3.45M
Buildings, Total	33.32M	17.54M	17.54M	17.54M	28.31M
Machinery, Total	68.72M	98.37M	96.06M	89.14M	87.7M
Full Time Employees	885	855	861	855	817
Accumulated Allowance for Doubtful Accounts (Supple)	44.21M	42.59M	44.13M	71.97M	89.32M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	132M	170M	210M	225M	203M
Depreciation & Amortization - CF	4.07M	14.62M	20.16M	20.83M	20.29M
Amortization of Goodwill and Intangible Assets - (CF)	5.29M	4.78M	3.24M	1.21M	419K
Depreciation & Amortization, Total	9.35M	19.39M	23.4M	22.05M	20.71M
Amortization of Deferred Charges, Total - (CF)	1.07M	767K	731K	617K	2.85M
(Gain) Loss From Sale Of Asset	-387K	-296K	765K	-708K	578K
(Gain) Loss on Sale of Investments - (CF)	-35.98M	-45.29M	9.06M	-36.52M	-9.91M
Asset Writedown & Restructuring Costs	312K	27.19M	-293K	244K	19.71K
Provision and Write-off of Bad Debts	5.45M	-1.61M	2.54M	27.88M	17.87M
Other Operating Activities, Total	89.07M	67.53M	138M	112M	73.12M
Change In Accounts Receivable	-639M	300M	-184M	-1.08B	473M
Change In Inventories	-6.88M	-484M	135M	-8.8M	-16.67M
Change In Accounts Payable	795M	267M	1.21B	-194M	-463M
Change In Deferred Taxes	1.82M	3.78M	-13.53M	-7.69M	4.81M
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	352M	325M	1.54B	-944M	307M
Capital Expenditure	-14.99M	-3.99M	-3.44M	-4.37M	-2.18M
Sale of Property, Plant, and Equipment	333K	1.15M	385K	20.07M	116K
Cash Acquisitions	-	-	-	-	-
Divestitures	8.19M	86.23M	-	-	4.5M
Investment in Marketable and Equity Securities, Total	-301M	-38.01M	-573M	210M	-210M
Other Investing Activities, Total	20.01M	32.64M	9.12M	24.35M	8.05M
Cash from Investing	-287M	78.02M	-567M	250M	-200M
Short Term Debt Issued, Total	-	1.58B	-	-	1.2B
Long-Term Debt Issued, Total	1.41B	-	1.2B	1.43B	-
Total Debt Issued	1.41B	1.58B	1.2B	1.43B	1.2B
Short Term Debt Repaid, Total	-	-1.76B	-	-	-1.3B
Long-Term Debt Repaid, Total	-1.03B	-10.55M	-1.25B	-1.61B	-11.43M
Total Debt Repaid	-1.03B	-1.77B	-1.25B	-1.61B	-1.31B
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-92.93M	-94.71M	-94.3M	-123M	-145M
Common & Preferred Stock Dividends Paid	-92.93M	-94.71M	-94.3M	-123M	-145M
Other Financing Activities, Total	2.25M	-25.41M	23.4M	-21.6M	-14.09M
Cash from Financing	281M	-313M	-123M	-328M	-271M
Foreign Exchange Rate Adjustments	-3.09M	8.31M	-89.78M	-15.31M	-582K
Net Change in Cash	343M	98.54M	756M	-1.04B	-164M
Supplemental Items
Cash Income Tax Paid (Refund)	-24.46M	-68.5M	-189M	-18.24M	11.04M
Levered Free Cash Flow	481M	178M	1.57B	-1.03B	-48.83M
Unlevered Free Cash Flow	509M	199M	1.59B	-1.02B	-34.81M
Change In Net Working Capital	-365M	-36.16M	-1.33B	1.21B	251M
Net Debt Issued / Repaid	372M	-193M	-52.38M	-183M	-112M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.41	3.35	4.26	2.87	3.36
Return on Total Capital	7.34	6.52	10.1	7.42	8.35
Return On Equity %	14.17	15.31	17.93	16.08	13.97
Return on Common Equity	13.37	15.51	16.9	16.31	13.74
Margin Analysis
Gross Profit Margin %	7.76	6.01	6.21	6.71	6.78
SG&A Margin	3.52	2.82	2.52	3.06	3.04
EBITDA Margin %	3.74	2.78	3.31	2.79	3.04
EBITA Margin %	3.67	2.72	3.23	2.7	2.95
EBIT Margin %	3.59	2.66	3.2	2.69	2.94
Income From Continuing Operations Margin %	2.33	2.1	2.12	2.37	2.16
Net Income Margin %	1.99	1.93	1.8	2.15	1.92
Net Avail. For Common Margin %	1.99	1.93	1.8	2.15	1.92
Normalized Net Income Margin	1.45	1.76	1.45	1.52	1.51
Levered Free Cash Flow Margin	7.25	2.02	13.43	-9.84	-0.46
Unlevered Free Cash Flow Margin	7.67	2.26	13.57	-9.74	-0.33
Asset Turnover
Asset Turnover	1.96	2.01	2.13	1.71	1.83
Fixed Assets Turnover	171.6	152.33	174.4	158.19	162.55
Receivables Turnover (Average Receivables)	15.24	21.44	44.98	10.31	6.23
Inventory Turnover (Average Inventory)	4.95	5.62	6.69	6.3	6.35
Short Term Liquidity
Current Ratio	1.34	1.31	1.29	1.31	1.37
Quick Ratio	0.76	0.5	0.73	0.78	0.81
Operating Cash Flow to Current Liabilities	0.12	0.09	0.33	-0.22	0.08
Days Sales Outstanding (Average Receivables)	24.02	17.02	8.12	35.39	58.71
Days Outstanding Inventory (Average Inventory)	73.95	64.97	54.53	57.95	57.6
Average Days Payable Outstanding	44.56	47.06	66.57	101.42	90.01
Cash Conversion Cycle (Average Days)	53.41	34.93	-3.92	-8.07	26.3
Long Term Solvency
Total Debt/Equity	98.36	74.73	61.29	46.94	38.13
Total Debt / Total Capital	49.59	42.77	38	31.94	27.6
LT Debt/Equity	-	0.43	7.11	0.58	0.26
Long-Term Debt / Total Capital	-	0.24	4.41	0.4	0.19
Total Liabilities / Total Assets	71.58	72.99	76.22	73.47	69.96
EBIT / Interest Expense	5.31	6.94	13.99	17.99	13.89
EBITDA / Interest Expense	5.52	7.52	14.87	19.4	14.81
(EBITDA - Capex) / Interest Expense	5.19	7.4	14.74	19.12	14.72
Total Debt / EBITDA	4.53	3.76	2.29	2.47	1.93
Net Debt / EBITDA	-1.55	-2.03	-5.08	-2.99	-2.3
Total Debt / (EBITDA - Capex)	4.83	3.82	2.31	2.5	1.94
Net Debt / (EBITDA - Capex)	-1.65	-2.06	-5.13	-3.04	-2.31
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	52.93	32.84	32.61	-10.59	1.3
Gross Profit, 1 Yr. Growth %	16.79	2.88	37.04	-3.48	2.38
EBITDA, 1 Yr. Growth %	27.6	-1.36	57.89	-24.52	10.16
EBITA, 1 Yr. Growth %	30.29	-1.92	57.49	-25.19	10.51
EBIT, 1 Yr. Growth %	31.81	-1.56	59.31	-24.87	10.84
Earnings From Cont. Operations, 1 Yr. Growth %	24.55	19.73	33.55	-0.12	-7.55
Net Income, 1 Yr. Growth %	11.41	28.59	23.5	6.91	-9.55
Normalized Net Income, 1 Yr. Growth %	11.75	61.97	9.17	-6.4	0.71
Diluted EPS Before Extra, 1 Yr. Growth %	11.42	28.6	23.5	6.91	-9.55
Accounts Receivable, 1 Yr. Growth %	151.25	-68.04	61.04	432.07	-0.93
Inventory, 1 Yr. Growth %	-0.21	38.76	-8.9	-1.73	2.43
Net Property, Plant and Equip., 1 Yr. Growth %	19.04	75.37	-18.13	18.96	-18.54
Total Assets, 1 Yr. Growth %	46.89	17.84	31.68	-3.81	-6.76
Tangible Book Value, 1 Yr. Growth %	8.8	23.7	17.19	9.31	5.68
Common Equity, 1 Yr. Growth %	7.24	14.23	12.57	9.21	5.62
Cash From Operations, 1 Yr. Growth %	60.86	-7.58	371.89	-161.49	-132.56
Capital Expenditures, 1 Yr. Growth %	461.03	-73.38	-13.75	26.92	-49.99
Levered Free Cash Flow, 1 Yr. Growth %	219.95	-63	782.33	-165.5	-95.26
Unlevered Free Cash Flow, 1 Yr. Growth %	184.6	-60.88	697.03	-164.2	-96.58
Dividend Per Share, 1 Yr. Growth %	19.99	16.66	57.16	14.53	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	33.35	42.53	32.73	8.89	-4.83
Gross Profit, 2 Yr. CAGR %	12.2	9.61	18.74	15.01	-0.59
EBITDA, 2 Yr. CAGR %	18.03	12.29	24.79	9.17	-8.81
EBITA, 2 Yr. CAGR %	21.76	13.15	24.28	8.55	-9.08
EBIT, 2 Yr. CAGR %	23.38	13.91	25.23	9.41	-8.74
Earnings From Cont. Operations, 2 Yr. CAGR %	16.04	22.11	26.45	15.48	-3.91
Net Income, 2 Yr. CAGR %	7.1	19.69	26.02	14.9	-1.66
Normalized Net Income, 2 Yr. CAGR %	1.15	34.54	32.87	1.09	-2.91
Diluted EPS Before Extra, 2 Yr. CAGR %	7.09	19.7	26.02	14.9	-1.66
Accounts Receivable, 2 Yr. CAGR %	52.27	-10.39	-28.26	192.72	129.6
Inventory, 2 Yr. CAGR %	4.05	17.67	12.43	-5.38	0.33
Net Property, Plant and Equip., 2 Yr. CAGR %	2.39	44.49	19.82	-1.31	-1.56
Total Assets, 2 Yr. CAGR %	24.77	31.56	24.57	12.57	-5.3
Tangible Book Value, 2 Yr. CAGR %	10.96	16.01	20.4	13.17	7.48
Common Equity, 2 Yr. CAGR %	8.85	10.68	13.39	10.87	7.4
Cash From Operations, 2 Yr. CAGR %	131.52	21.93	108.83	70.34	-55.26
Capital Expenditures, 2 Yr. CAGR %	29.14	22.22	-52.08	4.62	-20.33
Levered Free Cash Flow, 2 Yr. CAGR %	203.22	8.81	80.69	140.41	-82.37
Unlevered Free Cash Flow, 2 Yr. CAGR %	244.96	5.51	76.57	126.2	-85.19
Dividend Per Share, 2 Yr. CAGR %	20.01	18.31	35.4	34.16	7.02
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	23.76	33.18	39.15	16.35	6.3
Gross Profit, 3 Yr. CAGR %	8.06	9	18.08	10.82	10.64
EBITDA, 3 Yr. CAGR %	15.55	11.24	25.8	5.54	9.5
EBITA, 3 Yr. CAGR %	19.91	13.36	26.33	4.94	9.2
EBIT, 3 Yr. CAGR %	21.16	14.43	27.39	5.62	9.88
Earnings From Cont. Operations, 3 Yr. CAGR %	20.02	17.26	25.81	16.88	7.23
Net Income, 3 Yr. CAGR %	13.61	13.83	20.95	19.29	6.09
Normalized Net Income, 3 Yr. CAGR %	14.18	18.34	25.42	18.22	0.96
Diluted EPS Before Extra, 3 Yr. CAGR %	4.16	13.83	20.95	19.3	6.09
Accounts Receivable, 3 Yr. CAGR %	38.66	-9.51	8.94	39.9	103.99
Inventory, 3 Yr. CAGR %	-0.2	14.53	8.05	7.5	-2.85
Net Property, Plant and Equip., 3 Yr. CAGR %	-5.92	22.51	19.56	19.53	-7.42
Total Assets, 3 Yr. CAGR %	13.08	22.41	31.6	14.3	5.72
Tangible Book Value, 3 Yr. CAGR %	11.94	15.05	16.4	16.58	10.62
Common Equity, 3 Yr. CAGR %	9.39	10.62	11.3	11.98	9.09
Cash From Operations, 3 Yr. CAGR %	-12.12	70.47	91.43	38.93	-1.88
Capital Expenditures, 3 Yr. CAGR %	-35.32	-23.71	8.81	-33.7	-18.2
Levered Free Cash Flow, 3 Yr. CAGR %	6.54	50.4	118.6	28.84	-35.03
Unlevered Free Cash Flow, 3 Yr. CAGR %	7.03	66.97	107.02	26.02	-44.09
Dividend Per Share, 3 Yr. CAGR %	20.01	18.88	30.06	28.06	21.64
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.48	21.02	27.27	22.87	19.53
Gross Profit, 5 Yr. CAGR %	5.56	5.82	12.21	11.37	10.23
EBITDA, 5 Yr. CAGR %	11.67	10.94	19.21	10.41	10.61
EBITA, 5 Yr. CAGR %	12.61	12.9	21.69	11.41	10.76
EBIT, 5 Yr. CAGR %	12.22	12.98	22.77	12.4	11.48
Earnings From Cont. Operations, 5 Yr. CAGR %	13.15	17.1	22.55	16.54	12.95
Net Income, 5 Yr. CAGR %	8.45	15.82	18.42	14.26	11.34
Normalized Net Income, 5 Yr. CAGR %	5.75	20.65	21.32	11.08	13.21
Diluted EPS Before Extra, 5 Yr. CAGR %	2.39	9.34	12.41	14.26	11.34
Accounts Receivable, 5 Yr. CAGR %	13.49	-10.63	6.53	44.72	46.79
Inventory, 5 Yr. CAGR %	-1.77	5.11	4.67	6.1	4.89
Net Property, Plant and Equip., 5 Yr. CAGR %	-1.44	2.54	3.64	12.36	10.62
Total Assets, 5 Yr. CAGR %	9.85	12.93	17.54	18.38	15.38
Tangible Book Value, 5 Yr. CAGR %	24.8	33.36	15.25	14.3	12.74
Common Equity, 5 Yr. CAGR %	27.6	27.69	10.98	10.72	9.72
Cash From Operations, 5 Yr. CAGR %	6.73	16.41	24.24	70.42	7.03
Capital Expenditures, 5 Yr. CAGR %	-9.21	-35.89	-42.63	-13.44	-3.95
Levered Free Cash Flow, 5 Yr. CAGR %	0.02	24.85	31.61	81.44	-20.14
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.78	15.13	30.76	88.53	-27.92
Dividend Per Share, 5 Yr. CAGR %	-	-	25.94	24.77	20.3